iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
Kristin M SnyderKate J DixonZachary DavisMartin HoskingGeoffrey HartMelissa KhawAnders MatsonRyan BjordahlBryan HancockSoheila ShirinbakJeffrey S MillerBahram ValamehrJianming WuBruce WalcheckPublished in: Journal for immunotherapy of cancer (2023)
iNK cells expressing CD64/16A provide an off-the-shelf multiantigen targeting platform to address tumor heterogeneity and mitigate antigen escape.